Literature DB >> 26486479

[Management of hypothyroidism and hyperthyroidism].

Jan Jiskra.   

Abstract

Functional thyropathies present significant health risks for patients. Advanced functional thyropathies are always treated while indications for therapy of subclinical thyropathies are individual and often controversial. It is widely agreed that these disorders should be diagnosed and individuals should be followed. The drug of choice in substitution therapy of hypothyroidism is levothyroxine, in the treatment of hyperthyroidism it is methimazole. Administration of propylthiouracil should be limited to the first trimester of pregnancy, because its serious hepatotoxicity has been described. Hyperthyroidism based on thyroid nodules and immunogenic hyperthyroidism not reaching long-term remission, need to be treated radically: by surgery or radioiodine treatment. When radiation protection requirements are met, radioiodine can also be administered on an outpatient basis. Exceptionally, small doses of methimazole can be administered over an extended period of time in individual cases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26486479

Source DB:  PubMed          Journal:  Vnitr Lek        ISSN: 0042-773X


  2 in total

1.  Effects of vitamin D supplements on frequency of CD4+ T-cell subsets in women with Hashimoto's thyroiditis: a double-blind placebo-controlled study.

Authors:  Masoumeh Nodehi; Abolghasem Ajami; Maryam Izad; Hossein Asgarian Omran; Reza Chahardoli; Atieh Amouzegar; Saeed Yekaninejad; Mahbobeh Hemmatabadi; Fereydoon Azizi; Fatemeh Esfahanian; Fatemeh Mansouri; Ramin Mazaheri Nezhad Fard; Ali Akbar Saboor-Yaraghi
Journal:  Eur J Clin Nutr       Date:  2019-01-29       Impact factor: 4.016

2.  The Frequency of CD4+ T Cells in Women with Hashimoto's Thyroiditis.

Authors:  Masoume Nodehi; Abolghasem Ajami; Maryam Izad; Hossein Asgarian Omran; Fatemeh Esfahanian; Saeed Yekaninejad; Mahbobeh Hemmatabadi; Atieh Amouzegar; Reza Chahardoli; Fatemeh Mansouri; Ali Akbar Saboor-Yaraghi
Journal:  Int J Endocrinol Metab       Date:  2021-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.